FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to biotechnology. What is presented is a method for preparing a recombinant protein of type III interferon-like factor (ILF III) of the producing strain E. coli. The inclusion bodies E. coli are washed and dissolved with using 2% aqueous γ-cyclodextrin. That is followed by the sequential Ni-Sepharose, Q-Sepharose and SP-Sepharose chromatographic procedures. Refolding of a target protein is performed with using a mixture of cysteamine and cystamine at pH 10.5. The Amberchrome Profile XT20, Amberchrome Profile HPR10 and Kromasil 300-5C18 chromatographic procedures are sequentially performed.
EFFECT: invention enables optimising the ILF III purification environment at the stage of washing and dissolving the inclusion bodies Ecoli and provides 12% target protein yield.
3 dwg, 4 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PRODUCING SERRATIA MARCESCENS RECOMBINANT ENDONUCLEASE | 2021 |
|
RU2795623C2 |
METHOD FOR CLEANING THE MEDICAMENT OF PROLONGED ACTION ON THE BASIS OF THE RECOMBINANT ANALOGUE OF ALPHA-17 INTERFERON FOR VIRAL HEPATITIS C TREATMENT | 2017 |
|
RU2650755C1 |
METHOD FOR PURIFICATION OF SUSTAINED-RELEASE DRUG BASED ON RECOMBINANT INTERFERON BETA-1B ANALOGUE FOR THE TREATMENT OF MULTIPLE SCLEROSIS | 2017 |
|
RU2661088C1 |
METHOD FOR EXTRACTING AND PURIFYING RECOMBINANT PROTEIN, AN ANALOGUE OF A HUMAN KAPPA-CASEIN FRAGMENT HAVING CYTOTOXIC ACTIVITY TOWARDS HUMAN CANCER CELLS | 2018 |
|
RU2693251C1 |
METHOD FOR PURIFYING A RECOMBINANT ENZYME PREPARATION OF PHOSPHOLIPASE A2 FROM A PRODUCER STRAIN PICHIA PASTORIS | 2019 |
|
RU2746563C1 |
METHOD FOR PURIFICATION OF RECOMBINANT PROTEIN CONTAINING MYELOPEPTIDES SEQUENCES | 2016 |
|
RU2630302C1 |
METHOD OF INDUSTRIAL PURIFICATION OF ROMIPLOSTIM | 2021 |
|
RU2804622C2 |
METHOD OF PRODUCING A RECOMBINANT NUCLEASE CAS ESSENTIALLY FREE OF BACTERIAL ENDOTOXINS, THE PREPARATION OBTAINED BY THIS METHOD AND CONTAINING A KIT FOR USE IN A CRISPR/Cas SYSTEM | 2019 |
|
RU2707542C1 |
METHOD OF ISOLATION OF RECOMBINANT HUMAN TUMOR NECROSIS ALPHA-FACTOR | 1992 |
|
RU2101292C1 |
METHOD FOR OBTAINING A HYBRID PROTEIN CONTAINING A FUSED PROTEIN ANALOGUE OF AN INTERFERON GAMMA CONJUGATED WITH OLIGOSACCHARIDE | 2016 |
|
RU2656140C2 |
Authors
Dates
2015-04-27—Published
2012-06-29—Filed